Replicel Life Sciences Inc (RP.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 63 | 63 | 63 | 63 | 121 |
| Operating Expenses | 661 | 625 | 997 | 988 | 1,016 |
| Operating Income | -598 | -562 | -933 | -925 | -895 |
| Other Income | -14 | -14 | -6 | 98 | -17 |
| Pre-tax Income | -612 | -576 | -939 | -827 | -912 |
| Net Income Continuous | -612 | -576 | -939 | -827 | -912 |
| Net Income | $-612 | $-576 | $-939 | $-827 | $-912 |
| EPS Basic Total Ops | -0.03 | -0.02 | -0.03 | -0.03 | -0.03 |
| EPS Basic Continuous Ops | -0.03 | -0.02 | -0.03 | -0.03 | -0.03 |
| EPS Diluted Total Ops | -0.03 | -0.02 | -0.03 | -0.03 | -0.03 |
| EPS Diluted Continuous Ops | -0.03 | -0.02 | -0.03 | -0.03 | -0.03 |
| EBITDA(a) | $-597 | $-561 | $-933 | $-925 | $-894 |